Skip to main content

and
  1. Article

    Open Access

    Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

    Tomoyuki Homma, Noriyo Nagata, Masayuki Hashimoto in Scientific Reports (2024)

  2. Article

    Open Access

    Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

    Vaccines that efficiently target severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent for coronavirus disease (COVID-19), are the best means for controlling viral spread. This st...

    Tomoyuki Homma, Noriyo Nagata, Masayuki Hashimoto in Scientific Reports (2022)

  3. Article

    Open Access

    Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways

    In cultured cells, SARS-CoV-2 infects cells via multiple pathways using different host proteases. Recent studies have shown that the furin and TMPRSS2 (furin/TMPRSS2)-dependent pathway plays a minor role in in...

    Naoko Iwata-Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo in Nature Communications (2022)